Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case–control study

We conducted this case–control study to assess the role of vascular endothelial growth factor (VEGF) −2578C/A, +460T/C, +1612G/A, +936C/T, and −634G/C polymorphisms in the development of renal cell carcinoma (RCC), and analyzed the association of gene polymorphisms with demographic and clinical char...

Full description

Saved in:
Bibliographic Details
Published inTumor biology Vol. 36; no. 11; pp. 8645 - 8652
Main Authors Lu, Guangjian, Dong, Yuqian, Zhang, Qunmei, Jiao, Luyang, Yang, Shujuan, Shen, Beili
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.11.2015
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1010-4283
1423-0380
1423-0380
DOI10.1007/s13277-015-3431-1

Cover

Abstract We conducted this case–control study to assess the role of vascular endothelial growth factor (VEGF) −2578C/A, +460T/C, +1612G/A, +936C/T, and −634G/C polymorphisms in the development of renal cell carcinoma (RCC), and analyzed the association of gene polymorphisms with demographic and clinical characteristics of RCC. This study included 412 consecutive primary RCC patients and 824 controls. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to detect VEGF −2578C/A, +460T/C, +1612G/A, +936C/T, and −634G/C polymorphisms. Compared with the control subjects, the RCC cancer cases were more likely to have a habit of cigarette smoking, and suffered from hypertension and diabetes. Conditional logistic regression analysis showed that individuals carrying the AA genotype of −2578C/A were more likely to greatly increase risk of RCC, and the CC genotype of +460T/C revealed a significant association with increased risk of RCC. The CA + AA genotype of −2578C/A had a significantly increased risk of RCC in ever cigarette smokers, and individuals who suffered from hypertension and diabetes. TC + CC genotype of +460T/C was significantly associated with the elevated risk of RCC in those suffered from hypertension and diabetes. Our study suggests that −2578C/A and +460T/C polymorphisms of VEGF modulate the risk of developing RCC in Chinese population.
AbstractList We conducted this case-control study to assess the role of vascular endothelial growth factor (VEGF) -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C polymorphisms in the development of renal cell carcinoma (RCC), and analyzed the association of gene polymorphisms with demographic and clinical characteristics of RCC. This study included 412 consecutive primary RCC patients and 824 controls. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to detect VEGF -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C polymorphisms. Compared with the control subjects, the RCC cancer cases were more likely to have a habit of cigarette smoking, and suffered from hypertension and diabetes. Conditional logistic regression analysis showed that individuals carrying the AA genotype of -2578C/A were more likely to greatly increase risk of RCC, and the CC genotype of +460T/C revealed a significant association with increased risk of RCC. The CA + AA genotype of -2578C/A had a significantly increased risk of RCC in ever cigarette smokers, and individuals who suffered from hypertension and diabetes. TC + CC genotype of +460T/C was significantly associated with the elevated risk of RCC in those suffered from hypertension and diabetes. Our study suggests that -2578C/A and +460T/C polymorphisms of VEGF modulate the risk of developing RCC in Chinese population.We conducted this case-control study to assess the role of vascular endothelial growth factor (VEGF) -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C polymorphisms in the development of renal cell carcinoma (RCC), and analyzed the association of gene polymorphisms with demographic and clinical characteristics of RCC. This study included 412 consecutive primary RCC patients and 824 controls. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to detect VEGF -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C polymorphisms. Compared with the control subjects, the RCC cancer cases were more likely to have a habit of cigarette smoking, and suffered from hypertension and diabetes. Conditional logistic regression analysis showed that individuals carrying the AA genotype of -2578C/A were more likely to greatly increase risk of RCC, and the CC genotype of +460T/C revealed a significant association with increased risk of RCC. The CA + AA genotype of -2578C/A had a significantly increased risk of RCC in ever cigarette smokers, and individuals who suffered from hypertension and diabetes. TC + CC genotype of +460T/C was significantly associated with the elevated risk of RCC in those suffered from hypertension and diabetes. Our study suggests that -2578C/A and +460T/C polymorphisms of VEGF modulate the risk of developing RCC in Chinese population.
We conducted this case–control study to assess the role of vascular endothelial growth factor (VEGF) −2578C/A, +460T/C, +1612G/A, +936C/T, and −634G/C polymorphisms in the development of renal cell carcinoma (RCC), and analyzed the association of gene polymorphisms with demographic and clinical characteristics of RCC. This study included 412 consecutive primary RCC patients and 824 controls. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to detect VEGF −2578C/A, +460T/C, +1612G/A, +936C/T, and −634G/C polymorphisms. Compared with the control subjects, the RCC cancer cases were more likely to have a habit of cigarette smoking, and suffered from hypertension and diabetes. Conditional logistic regression analysis showed that individuals carrying the AA genotype of −2578C/A were more likely to greatly increase risk of RCC, and the CC genotype of +460T/C revealed a significant association with increased risk of RCC. The CA + AA genotype of −2578C/A had a significantly increased risk of RCC in ever cigarette smokers, and individuals who suffered from hypertension and diabetes. TC + CC genotype of +460T/C was significantly associated with the elevated risk of RCC in those suffered from hypertension and diabetes. Our study suggests that −2578C/A and +460T/C polymorphisms of VEGF modulate the risk of developing RCC in Chinese population.
We conducted this case-control study to assess the role of vascular endothelial growth factor (VEGF) -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C polymorphisms in the development of renal cell carcinoma (RCC), and analyzed the association of gene polymorphisms with demographic and clinical characteristics of RCC. This study included 412 consecutive primary RCC patients and 824 controls. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to detect VEGF -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C polymorphisms. Compared with the control subjects, the RCC cancer cases were more likely to have a habit of cigarette smoking, and suffered from hypertension and diabetes. Conditional logistic regression analysis showed that individuals carrying the AA genotype of -2578C/A were more likely to greatly increase risk of RCC, and the CC genotype of +460T/C revealed a significant association with increased risk of RCC. The CA+AA genotype of -2578C/A had a significantly increased risk of RCC in ever cigarette smokers, and individuals who suffered from hypertension and diabetes. TC+CC genotype of +460T/C was significantly associated with the elevated risk of RCC in those suffered from hypertension and diabetes. Our study suggests that -2578C/A and +460T/C polymorphisms of VEGF modulate the risk of developing RCC in Chinese population.
Author Jiao, Luyang
Dong, Yuqian
Shen, Beili
Zhang, Qunmei
Yang, Shujuan
Lu, Guangjian
Author_xml – sequence: 1
  givenname: Guangjian
  surname: Lu
  fullname: Lu, Guangjian
  email: shenbeili_zph@163.com
  organization: Clinical Laboratory, The First Affiliated Hospital of Xinxiang Medical University
– sequence: 2
  givenname: Yuqian
  surname: Dong
  fullname: Dong, Yuqian
  organization: Clinical Laboratory, The First Affiliated Hospital of Xinxiang Medical University
– sequence: 3
  givenname: Qunmei
  surname: Zhang
  fullname: Zhang, Qunmei
  organization: Blood Transfusion Room, The First Affiliated Hospital of Xinxiang Medical University
– sequence: 4
  givenname: Luyang
  surname: Jiao
  fullname: Jiao, Luyang
  organization: Clinical Laboratory, The First Affiliated Hospital of Xinxiang Medical University
– sequence: 5
  givenname: Shujuan
  surname: Yang
  fullname: Yang, Shujuan
  organization: Department of Health and Social Behavior, West China School of Public Health, Sichuan University
– sequence: 6
  givenname: Beili
  surname: Shen
  fullname: Shen, Beili
  organization: Department of Renal Transplantation, Zhengzhou People’s Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26044558$$D View this record in MEDLINE/PubMed
BookMark eNp9kctqFjEUx4O02Is-gBsJuHEzmtvk4k6KNyjYha5DbtMvdWbymWQq306fwTf0Scz0a0EKdpOcwO93OCf_E3AwpzkA8AyjVxgh8bpgSoToEO47yiju8CNwjBmhHaISHbQaYdQxIukROCnlCjVQKf4YHBGOGOt7eQx-XeTgo6vxOsBrMy4BpqEVxS2jyTDMPtVNGKMZ4WVOP-oGDsbVlOE2jbsp5e0mlqnANMOGwRzLt9XPYW6CC2M7THZxTpMpb6BprxL-_Pzt0lxzGmGpi989AYeDGUt4enufgq_v3305-9idf_7w6ezteecYI7Ujyg8ScYuI4AQrbr003IhgnLJM2J5RRSWXStjBDyJYy733ilFmZd8PtKen4OW-7zan70soVU-xrDOaOaSlaCyYoERRwRv64h56lZbcdrqhFEe0R7JRz2-pxU7B622Ok8k7ffe5DRB7wOVUSg6DdrGaGtftTRw1RnqNUe9j1C0dvcaocTPxPfOu-UMO2TulsfNlyP8M_V_pL1R8sPs
CitedBy_id crossref_primary_10_1159_000505817
crossref_primary_10_1186_s41021_021_00185_3
crossref_primary_10_18632_oncotarget_17293
crossref_primary_10_1177_1533034617712396
crossref_primary_10_18632_oncotarget_17833
crossref_primary_10_3389_fphys_2018_00715
crossref_primary_10_1016_j_mgene_2022_101017
crossref_primary_10_1097_MD_0000000000034089
crossref_primary_10_18632_oncotarget_14263
crossref_primary_10_1016_j_gene_2018_09_005
Cites_doi 10.1006/cyto.2000.0692
10.3892/ol.2013.1499
10.1200/JCO.2005.06.081
10.1194/jlr.P030551
10.1093/jnci/djh014
10.1016/j.febslet.2006.03.087
10.1016/j.juro.2010.06.009
10.1155/2014/932481
10.1371/journal.pone.0016982
10.1089/gtmb.2011.0029
10.1007/s13277-013-1173-5
10.3233/CBM-130348
10.1016/j.oraloncology.2012.05.023
10.3892/mmr.2013.1607
10.1002/cncr.20749
10.1007/s12032-014-0193-3
10.1371/journal.pone.0005798
10.1093/aje/kwn122
10.1016/j.humimm.2012.10.014
10.1371/journal.pone.0019773
10.1007/s00384-008-0586-x
10.2337/diacare.17.2.115
10.1016/j.lfs.2006.12.033
10.1007/s13277-013-1475-7
10.1007/s12032-013-0509-8
10.3892/mmr.2014.1890
10.1016/S0002-9440(10)64859-6
10.1038/nrc909
10.7314/APJCP.2014.15.10.4211
10.1016/j.canlet.2003.11.032
10.1093/toxsci/kfm060
10.1093/annonc/mds022
ContentType Journal Article
Copyright International Society of Oncology and BioMarkers (ISOBM) 2015
Copyright_xml – notice: International Society of Oncology and BioMarkers (ISOBM) 2015
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TO
7X7
7XB
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7P
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOI 10.1007/s13277-015-3431-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Research Library
Biological Science Database
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Publicly Available Content Database
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1423-0380
EndPage 8652
ExternalDocumentID 3897217061
26044558
10_1007_s13277_015_3431_1
Genre Journal Article
Feature
GroupedDBID ---
.GJ
06D
0VX
0VY
0~B
123
1N0
203
29Q
29~
2KM
2LR
2VQ
30V
30W
328
36B
3V.
4.4
408
40D
53G
67N
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8UI
8UJ
96X
AAIAL
AAJKR
AARHV
AARTL
AASGM
AAWCG
AAYIC
AAYIU
AAYQN
AAYTO
AAYZH
AAZMS
ABBTS
ABJOX
ABPLI
ABQXT
ABTEG
ABTHY
ABTMW
ABUWG
ABWCG
ACBXY
ACGFS
ACKNC
ACPQW
ACPRK
ACQXL
ADAGL
ADBBV
ADHIR
ADINQ
ADKPE
ADZMO
AEGNC
AEJHL
AENEX
AEOHA
AEPYU
AETCA
AEWDL
AEYAO
AFBBN
AFCOW
AFDXO
AFKRA
AFKRG
AFLOW
AFRWT
AFSIO
AFWTZ
AFZKB
AGAYW
AGJBK
AGQMX
AGWZB
AGYKE
AHAVH
AHBYD
AHMBA
AHSBF
AHYZX
AIIXL
AIOMO
AJBLW
AJUZI
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
ANMIH
AUTPY
AYAKG
AZQEC
BBNVY
BCNDV
BDDNI
BENPR
BGNMA
BHPHI
BPHCQ
BSEHC
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
CYUIP
DU5
DV7
DWQXO
E0A
EBD
EBS
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FB.
FRRFC
FYJPI
FYUFA
GGRSB
GNUQQ
GQ6
GQ7
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GUQSH
H13
HCIFZ
HF~
HMCUK
HMJXF
HRMNR
HZ~
IOS
ITM
J0Z
J8X
JBSCW
K.F
KOV
LK8
M1P
M2O
M4Y
M7P
N9A
NQS
NU0
O1H
O9-
O93
O9I
OK1
PADUT
PIMPY
PQQKQ
PROAC
PSQYO
Q2X
R9I
RIG
RKO
ROL
RSV
RXVBD
S1Z
S27
S3A
S3B
SAUOL
SBL
SFC
SHX
SOJ
SV3
T13
U2A
U9L
UDS
UG4
UJ6
UKHRP
VC2
W48
WK8
Z45
ZOVNA
ZXP
~A9
0R~
AAYXX
ABFSG
ACHEB
ACSTC
AEZWR
AFHIU
AHWEU
AIXLP
CITATION
PHGZM
PHGZT
SCNPE
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7T5
7TO
7XB
8FK
H94
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
ID FETCH-LOGICAL-c442t-29df806b02762196bd8a6a7eac9b47b5439386897bfdf7ebb6ddd9434b855f353
IEDL.DBID AGYKE
ISSN 1010-4283
1423-0380
IngestDate Fri Sep 05 02:45:06 EDT 2025
Sat Aug 23 13:38:27 EDT 2025
Mon Jul 21 06:03:36 EDT 2025
Thu Apr 24 23:05:48 EDT 2025
Tue Jul 01 02:37:26 EDT 2025
Fri Feb 21 02:38:40 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Vascular endothelial growth factor
Renal cell carcinomas
Polymorphism
Cancer risk
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c442t-29df806b02762196bd8a6a7eac9b47b5439386897bfdf7ebb6ddd9434b855f353
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.proquest.com/docview/1749603508?pq-origsite=%requestingapplication%
PMID 26044558
PQID 1749603508
PQPubID 33651
PageCount 8
ParticipantIDs proquest_miscellaneous_1747329376
proquest_journals_1749603508
pubmed_primary_26044558
crossref_citationtrail_10_1007_s13277_015_3431_1
crossref_primary_10_1007_s13277_015_3431_1
springer_journals_10_1007_s13277_015_3431_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-11-01
PublicationDateYYYYMMDD 2015-11-01
PublicationDate_xml – month: 11
  year: 2015
  text: 2015-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: United States
– name: London
PublicationSubtitle Tumor Markers, Tumor Targeting and Translational Cancer Research
PublicationTitle Tumor biology
PublicationTitleAbbrev Tumor Biol
PublicationTitleAlternate Tumour Biol
PublicationYear 2015
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References ConklinBSZhaoWZhongDSChenCNicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cellsAm J Pathol2002160241381:CAS:528:DC%2BD38XitVClu7g%3D10.1016/S0002-9440(10)64859-6118395601850669
WongHPYuLLamEKTaiEKWuWKChoCHNicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activationToxicol Sci2007972279871:CAS:528:DC%2BD2sXmsV2jurY%3D10.1093/toxsci/kfm06017369603Epub 2007 Mar 16
GLOBOCAN. Estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer. 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx
Sáenz-LópezPVazquezFCozarJMCarreteroRGarridoFRuiz-CabelloFVEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish populationHum Immunol20137419810310.1016/j.humimm.2012.10.01423073296Epub 2012 Oct 13
PerroneGVincenziBSantiniDCorrelation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinicopathological features in colon cancerCancer Lett2004208227341:CAS:528:DC%2BD2cXktVOls74%3D10.1016/j.canlet.2003.11.03215142682
StathopoulouMGBonnefondANdiayeNCAzimi-NezhadMEl ShamiehSSalehAA common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-CJ Lipid Res.2013542535411:CAS:528:DC%2BC3sXosF2hug%3D%3D10.1194/jlr.P030551232042973546029
AjazSKhaliqSAbidAHassanASHashmiASultanGAssociation of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinomaGenet Test Mol Biomarkers201115965371:CAS:528:DC%2BC3MXhtFKnt7jP10.1089/gtmb.2011.002921491998Epub 2011 Apr 14
IordacheSSaftoiuAGeorgescuCVVascular endothelial growth factor expression and microvessel density—two useful tools for the assessment of prognosis and survival in gastric cancer patientsJ Gastrointestin Liver Dis201019135920593045
WatsonCJWebbNJBottomleyMJBrenchleyPEIdentification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein productionCytokine2000128123251:CAS:528:DC%2BD3cXltlOqsbw%3D10.1006/cyto.2000.069210930302
ZhangYLiSXiaoHQHuZXXuYCHuangQVascular endothelial growth factor gene polymorphisms and renal cell carcinoma: a systematic review and meta-analysisOncol Lett201364106878241374663796421Epub 2013 Jul 29
Sa-NguanraksaDKooptiwutSChuangsuwanichTPongpruttipanTMalasitPO-CharoenratPVascular endothelial growth factor polymorphisms affect gene expression and tumor aggressiveness in patients with breast cancerMol Med Rep201493104481:CAS:528:DC%2BC2cXktFers70%3D24401996
BelloccoRPasqualiERotaMBagnardiVTramacereIScottiLAlcohol drinking and risk of renal cell carcinoma: results of a meta-analysisAnn Oncol20122392235441:STN:280:DC%2BC38vlsl2ktA%3D%3D10.1093/annonc/mds02222398178
OuCZhaoHLZhuBHuangLSLiPZLaoMAssociation of vitamin D receptor gene polymorphism with the risk of renal cell carcinoma: a meta-analysisJ Recept Signal Transduct Res20141916
JaiswalPKTripathiNShuklaAMittalRDAssociation of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer riskMed Oncol201330250910.1007/s12032-013-0509-823430447Epub 2013 Feb 21
WangZWenPLuoXFangXWangQMaFAssociation of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese populationTumour Biol20143543605101:CAS:528:DC%2BC2cXmtlWktLw%3D10.1007/s13277-013-1475-724310504Epub 2013 Dec 6
FicarraVMartignoniGMaffeiNBrunelliMNovaraGZanollaLOriginal and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinomaCancer20051031687510.1002/cncr.2074915573369
FacchiniFChenYDReavenGMLight-to-moderate alcohol intake is associated with enhanced insulin sensitivityDiabetes Care199417211591:STN:280:DyaK2c7osFCrsQ%3D%3D10.2337/diacare.17.2.1157907975
AdamsKFLeitzmannMFAlbanesDKipnisVMooreSCSchatzkinABody size and renal cell cancer incidence in a large US cohort studyAm J Epidemiol2008168326877185445712727262Epub 2008 Jun 9
EvensenLMicklemDRBloisABergeSVAarsaetherNLittlewood-EvansAMural cell associated VEGF is required for organotypic vessel formationPLoS One20094610.1371/journal.pone.0005798194954222688382
Barbera-GuillemENyhusJKWolfordCCFrieceCRSampselJWVascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the processCancer Res20026223704291:CAS:528:DC%2BD38XpsVahtr8%3D12460925
FerraraNVEGF and the quest for tumour angiogenesis factorsNat Rev Cancer20022107958031:CAS:528:DC%2BD38XnsVGrtbk%3D10.1038/nrc90912360282
Sa-NguanraksaDChuangsuwanichTPongpruttipanTKummalueTRojananinSRatanawichhitrasinAVascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressivenessMol Med Rep2013841242501:CAS:528:DC%2BC3sXhs1elsbvK23904001Epub 2013 Jul 31
AtilganDParlaktasBSUluocakNKolukcuEErdemirFOzyurtHThe relationship between ALA16VAL single gene polymorphism and renal cell carcinomaAdv Urol2014201493248110.1155/2014/932481245877993920972
MuHJZouJXiePXuZQRuanJYangSDAssociation of leptin receptor Lys109Arg and Gln223Arg polymorphisms with increased risk of clear cell renal cell carcinomaAsian Pac J Cancer Prev201415104211510.7314/APJCP.2014.15.10.421124935373
Martinez-FierroMLGarza-VelozIRojas-MartinezAOrtiz-LopezRCastruita-de la RosaCOrtiz-CastroYPositive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancerCancer Biomark2013134235411:CAS:528:DC%2BC3sXhslKgt7fL10.3233/CBM-13034824240584
BruyèreFHovensCMMarsonMNd'ArcierBFCostelloAJWatierHVEGF polymorphisms are associated with an increasing risk of developing renal cell carcinomaJ Urol201018441273810.1016/j.juro.2010.06.00920723915
HicklinDJEllisLMRole of the vascular endothelial growth factor pathway in tumor growth and angiogenesisJ Clin Oncol20052351011271:CAS:528:DC%2BD2MXit1Gnsro%3D10.1200/JCO.2005.06.08115585754
Rinck-JuniorJAOliveiraCLourençoGJSagarraRADerchainSFSegallaJGVascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancerJ Cancer Res Clin Oncol201493813639
VineisPAlavanjaMBufflerPFonthamEFranceschiSGaoYTTobacco and cancer: recent epidemiological evidenceJ Natl Cancer Inst2004962991061:STN:280:DC%2BD2c%2FjsV2rsw%3D%3D10.1093/jnci/djh01414734699
KandaYWatanabeYNicotine-induced vascular endothelial growth factor release via the EGFR-ERK pathway in rat vascular smooth muscle cellsLife Sci200780151409141:CAS:528:DC%2BD2sXislKgt7g%3D10.1016/j.lfs.2006.12.03317286987Epub 2007 Jan 17
KushnerEJBautchVLBuilding blood vessels in development and diseaseCurr Opin Hematol2013203231623567339
SupicGJovicNZeljicKKozomaraRMagicZAssociation of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patientsOral Oncol20124811117171:CAS:528:DC%2BC38XhtV2itLjN10.1016/j.oraloncology.2012.05.02322818823Epub 2012 Jul 18
HongTTCaiDYWuXHHuaDThree vascular endothelial growth factor polymorphisms (−460C > T, −2578C > A, 1612G > A) with cancer risk: a meta-analysis based on 30 case–control studiesCancer Invest201129747271:CAS:528:DC%2BC3MXos1Grt7s%3D21740084
AndersenSDonnemTAl-ShibliKAl-SaadSStenvoldHBusundLTPrognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2PLoS One201165e197731:CAS:528:DC%2BC3MXmsFGktbk%3D10.1371/journal.pone.0019773216036283095634
StefanouDBatistatouAKaminaSExpression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancerIn Vivo200418155601:CAS:528:DC%2BD2cXjslGjsro%3D15113042
MaltesePCanestrariERuzzoAGrazianoFFalconeALoupakisFVEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian populationInt J Colorectal Dis20092421657010.1007/s00384-008-0586-x18830612Epub 2008 Oct 2
RahouiJLaraquiASbittiYTouilNIbrahimiAGhrabBInvestigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case–control studyMed Oncol201431919310.1007/s12032-014-0193-325148899Epub 2014 Aug 23
RoyHBhardwajSYlä-HerttualaSBiology of vascular endothelial growth factorsFEBS Lett2006580122879871:CAS:528:DC%2BD28XltVKnt7g%3D10.1016/j.febslet.2006.03.08716631753Epub 2006 Apr 17
RuggieroDDalmassoCNutileTSoriceRDionisiLAversanoMGenetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphismsPLoS One201162e169821:CAS:528:DC%2BC3MXitlyjtbo%3D10.1371/journal.pone.0016982213473903036731
XuYZhuSAssociations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysisTumour Biol20143521307111:CAS:528:DC%2BC2cXjtlCqtbw%3D10.1007/s13277-013-1173-524127038Epub 2013 Oct 15
R Bellocco (3431_CR3) 2012; 23
D Ruggiero (3431_CR15) 2011; 6
E Barbera-Guillem (3431_CR9) 2002; 62
Y Kanda (3431_CR39) 2007; 80
D Atilgan (3431_CR8) 2014; 2014
N Ferrara (3431_CR11) 2002; 2
P Sáenz-López (3431_CR21) 2013; 74
V Ficarra (3431_CR24) 2005; 103
EJ Kushner (3431_CR25) 2013; 20
BS Conklin (3431_CR38) 2002; 160
HJ Mu (3431_CR6) 2014; 15
S Andersen (3431_CR13) 2011; 6
S Iordache (3431_CR27) 2010; 19
G Supic (3431_CR36) 2012; 48
Y Zhang (3431_CR23) 2013; 6
Y Xu (3431_CR34) 2014; 35
D Stefanou (3431_CR29) 2004; 18
CJ Watson (3431_CR14) 2000; 12
TT Hong (3431_CR37) 2011; 29
J Rahoui (3431_CR31) 2014; 31
PK Jaiswal (3431_CR33) 2013; 30
HP Wong (3431_CR40) 2007; 97
H Roy (3431_CR26) 2006; 580
D Sa-Nguanraksa (3431_CR19) 2014; 9
L Evensen (3431_CR10) 2009; 4
P Vineis (3431_CR2) 2004; 96
D Sa-Nguanraksa (3431_CR35) 2013; 8
ML Martinez-Fierro (3431_CR17) 2013; 13
3431_CR1
C Ou (3431_CR7) 2014; 19
Z Wang (3431_CR18) 2014; 35
F Bruyère (3431_CR22) 2010; 184
JA Rinck-Junior (3431_CR16) 2014; 93
DJ Hicklin (3431_CR12) 2005; 23
F Facchini (3431_CR5) 1994; 17
S Ajaz (3431_CR20) 2011; 15
G Perrone (3431_CR28) 2004; 208
MG Stathopoulou (3431_CR30) 2013; 54
KF Adams (3431_CR4) 2008; 168
P Maltese (3431_CR32) 2009; 24
18830612 - Int J Colorectal Dis. 2009 Feb;24(2):165-70
24310504 - Tumour Biol. 2014 Apr;35(4):3605-10
24240584 - Cancer Biomark. 2013;13(4):235-41
21603628 - PLoS One. 2011;6(5):e19773
23073296 - Hum Immunol. 2013 Jan;74(1):98-103
24137466 - Oncol Lett. 2013 Oct;6(4):1068-1078
15573369 - Cancer. 2005 Jan 1;103(1):68-75
12460925 - Cancer Res. 2002 Dec 1;62(23):7042-9
22398178 - Ann Oncol. 2012 Sep;23(9):2235-44
18544571 - Am J Epidemiol. 2008 Aug 1;168(3):268-77
15585754 - J Clin Oncol. 2005 Feb 10;23(5):1011-27
23204297 - J Lipid Res. 2013 Feb;54(2):535-41
23567339 - Curr Opin Hematol. 2013 May;20(3):231-6
24840096 - J Recept Signal Transduct Res. 2014 Dec;34(6):463-8
21347390 - PLoS One. 2011 Feb 09;6(2):e16982
14734699 - J Natl Cancer Inst. 2004 Jan 21;96(2):99-106
22818823 - Oral Oncol. 2012 Nov;48(11):1171-7
24401996 - Mol Med Rep. 2014 Mar;9(3):1044-8
24935373 - Asian Pac J Cancer Prev. 2014;15(10):4211-5
12360282 - Nat Rev Cancer. 2002 Oct;2(10):795-803
25148899 - Med Oncol. 2014 Sep;31(9):193
15113042 - In Vivo. 2004 Mar-Apr;18(2):155-60
20723915 - J Urol. 2010 Oct;184(4):1273-8
19495422 - PLoS One. 2009 Jun 04;4(6):e5798
23430447 - Med Oncol. 2013 Jun;30(2):509
23904001 - Mol Med Rep. 2013 Oct;8(4):1242-50
24127038 - Tumour Biol. 2014 Feb;35(2):1307-11
21740084 - Cancer Invest. 2011 Aug;29(7):472-7
16631753 - FEBS Lett. 2006 May 22;580(12):2879-87
15142682 - Cancer Lett. 2004 May 28;208(2):227-34
17369603 - Toxicol Sci. 2007 Jun;97(2):279-87
10930302 - Cytokine. 2000 Aug;12(8):1232-5
20593045 - J Gastrointestin Liver Dis. 2010 Jun;19(2):135-9
7907975 - Diabetes Care. 1994 Feb;17(2):115-9
21491998 - Genet Test Mol Biomarkers. 2011 Sep;15(9):653-7
17286987 - Life Sci. 2007 Mar 20;80(15):1409-14
11839560 - Am J Pathol. 2002 Feb;160(2):413-8
24587799 - Adv Urol. 2014;2014:932481
References_xml – reference: WangZWenPLuoXFangXWangQMaFAssociation of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese populationTumour Biol20143543605101:CAS:528:DC%2BC2cXmtlWktLw%3D10.1007/s13277-013-1475-724310504Epub 2013 Dec 6
– reference: IordacheSSaftoiuAGeorgescuCVVascular endothelial growth factor expression and microvessel density—two useful tools for the assessment of prognosis and survival in gastric cancer patientsJ Gastrointestin Liver Dis201019135920593045
– reference: Sáenz-LópezPVazquezFCozarJMCarreteroRGarridoFRuiz-CabelloFVEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish populationHum Immunol20137419810310.1016/j.humimm.2012.10.01423073296Epub 2012 Oct 13
– reference: JaiswalPKTripathiNShuklaAMittalRDAssociation of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer riskMed Oncol201330250910.1007/s12032-013-0509-823430447Epub 2013 Feb 21
– reference: WongHPYuLLamEKTaiEKWuWKChoCHNicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activationToxicol Sci2007972279871:CAS:528:DC%2BD2sXmsV2jurY%3D10.1093/toxsci/kfm06017369603Epub 2007 Mar 16
– reference: RoyHBhardwajSYlä-HerttualaSBiology of vascular endothelial growth factorsFEBS Lett2006580122879871:CAS:528:DC%2BD28XltVKnt7g%3D10.1016/j.febslet.2006.03.08716631753Epub 2006 Apr 17
– reference: MuHJZouJXiePXuZQRuanJYangSDAssociation of leptin receptor Lys109Arg and Gln223Arg polymorphisms with increased risk of clear cell renal cell carcinomaAsian Pac J Cancer Prev201415104211510.7314/APJCP.2014.15.10.421124935373
– reference: Sa-NguanraksaDKooptiwutSChuangsuwanichTPongpruttipanTMalasitPO-CharoenratPVascular endothelial growth factor polymorphisms affect gene expression and tumor aggressiveness in patients with breast cancerMol Med Rep201493104481:CAS:528:DC%2BC2cXktFers70%3D24401996
– reference: KandaYWatanabeYNicotine-induced vascular endothelial growth factor release via the EGFR-ERK pathway in rat vascular smooth muscle cellsLife Sci200780151409141:CAS:528:DC%2BD2sXislKgt7g%3D10.1016/j.lfs.2006.12.03317286987Epub 2007 Jan 17
– reference: FerraraNVEGF and the quest for tumour angiogenesis factorsNat Rev Cancer20022107958031:CAS:528:DC%2BD38XnsVGrtbk%3D10.1038/nrc90912360282
– reference: RahouiJLaraquiASbittiYTouilNIbrahimiAGhrabBInvestigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case–control studyMed Oncol201431919310.1007/s12032-014-0193-325148899Epub 2014 Aug 23
– reference: StathopoulouMGBonnefondANdiayeNCAzimi-NezhadMEl ShamiehSSalehAA common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-CJ Lipid Res.2013542535411:CAS:528:DC%2BC3sXosF2hug%3D%3D10.1194/jlr.P030551232042973546029
– reference: SupicGJovicNZeljicKKozomaraRMagicZAssociation of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patientsOral Oncol20124811117171:CAS:528:DC%2BC38XhtV2itLjN10.1016/j.oraloncology.2012.05.02322818823Epub 2012 Jul 18
– reference: AjazSKhaliqSAbidAHassanASHashmiASultanGAssociation of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinomaGenet Test Mol Biomarkers201115965371:CAS:528:DC%2BC3MXhtFKnt7jP10.1089/gtmb.2011.002921491998Epub 2011 Apr 14
– reference: StefanouDBatistatouAKaminaSExpression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancerIn Vivo200418155601:CAS:528:DC%2BD2cXjslGjsro%3D15113042
– reference: RuggieroDDalmassoCNutileTSoriceRDionisiLAversanoMGenetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphismsPLoS One201162e169821:CAS:528:DC%2BC3MXitlyjtbo%3D10.1371/journal.pone.0016982213473903036731
– reference: AndersenSDonnemTAl-ShibliKAl-SaadSStenvoldHBusundLTPrognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2PLoS One201165e197731:CAS:528:DC%2BC3MXmsFGktbk%3D10.1371/journal.pone.0019773216036283095634
– reference: WatsonCJWebbNJBottomleyMJBrenchleyPEIdentification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein productionCytokine2000128123251:CAS:528:DC%2BD3cXltlOqsbw%3D10.1006/cyto.2000.069210930302
– reference: PerroneGVincenziBSantiniDCorrelation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinicopathological features in colon cancerCancer Lett2004208227341:CAS:528:DC%2BD2cXktVOls74%3D10.1016/j.canlet.2003.11.03215142682
– reference: HongTTCaiDYWuXHHuaDThree vascular endothelial growth factor polymorphisms (−460C > T, −2578C > A, 1612G > A) with cancer risk: a meta-analysis based on 30 case–control studiesCancer Invest201129747271:CAS:528:DC%2BC3MXos1Grt7s%3D21740084
– reference: EvensenLMicklemDRBloisABergeSVAarsaetherNLittlewood-EvansAMural cell associated VEGF is required for organotypic vessel formationPLoS One20094610.1371/journal.pone.0005798194954222688382
– reference: BruyèreFHovensCMMarsonMNd'ArcierBFCostelloAJWatierHVEGF polymorphisms are associated with an increasing risk of developing renal cell carcinomaJ Urol201018441273810.1016/j.juro.2010.06.00920723915
– reference: GLOBOCAN. Estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer. 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx
– reference: KushnerEJBautchVLBuilding blood vessels in development and diseaseCurr Opin Hematol2013203231623567339
– reference: FicarraVMartignoniGMaffeiNBrunelliMNovaraGZanollaLOriginal and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinomaCancer20051031687510.1002/cncr.2074915573369
– reference: MaltesePCanestrariERuzzoAGrazianoFFalconeALoupakisFVEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian populationInt J Colorectal Dis20092421657010.1007/s00384-008-0586-x18830612Epub 2008 Oct 2
– reference: Martinez-FierroMLGarza-VelozIRojas-MartinezAOrtiz-LopezRCastruita-de la RosaCOrtiz-CastroYPositive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancerCancer Biomark2013134235411:CAS:528:DC%2BC3sXhslKgt7fL10.3233/CBM-13034824240584
– reference: XuYZhuSAssociations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysisTumour Biol20143521307111:CAS:528:DC%2BC2cXjtlCqtbw%3D10.1007/s13277-013-1173-524127038Epub 2013 Oct 15
– reference: Rinck-JuniorJAOliveiraCLourençoGJSagarraRADerchainSFSegallaJGVascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancerJ Cancer Res Clin Oncol201493813639
– reference: AdamsKFLeitzmannMFAlbanesDKipnisVMooreSCSchatzkinABody size and renal cell cancer incidence in a large US cohort studyAm J Epidemiol2008168326877185445712727262Epub 2008 Jun 9
– reference: BelloccoRPasqualiERotaMBagnardiVTramacereIScottiLAlcohol drinking and risk of renal cell carcinoma: results of a meta-analysisAnn Oncol20122392235441:STN:280:DC%2BC38vlsl2ktA%3D%3D10.1093/annonc/mds02222398178
– reference: ZhangYLiSXiaoHQHuZXXuYCHuangQVascular endothelial growth factor gene polymorphisms and renal cell carcinoma: a systematic review and meta-analysisOncol Lett201364106878241374663796421Epub 2013 Jul 29
– reference: Sa-NguanraksaDChuangsuwanichTPongpruttipanTKummalueTRojananinSRatanawichhitrasinAVascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressivenessMol Med Rep2013841242501:CAS:528:DC%2BC3sXhs1elsbvK23904001Epub 2013 Jul 31
– reference: FacchiniFChenYDReavenGMLight-to-moderate alcohol intake is associated with enhanced insulin sensitivityDiabetes Care199417211591:STN:280:DyaK2c7osFCrsQ%3D%3D10.2337/diacare.17.2.1157907975
– reference: AtilganDParlaktasBSUluocakNKolukcuEErdemirFOzyurtHThe relationship between ALA16VAL single gene polymorphism and renal cell carcinomaAdv Urol2014201493248110.1155/2014/932481245877993920972
– reference: VineisPAlavanjaMBufflerPFonthamEFranceschiSGaoYTTobacco and cancer: recent epidemiological evidenceJ Natl Cancer Inst2004962991061:STN:280:DC%2BD2c%2FjsV2rsw%3D%3D10.1093/jnci/djh01414734699
– reference: OuCZhaoHLZhuBHuangLSLiPZLaoMAssociation of vitamin D receptor gene polymorphism with the risk of renal cell carcinoma: a meta-analysisJ Recept Signal Transduct Res20141916
– reference: ConklinBSZhaoWZhongDSChenCNicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cellsAm J Pathol2002160241381:CAS:528:DC%2BD38XitVClu7g%3D10.1016/S0002-9440(10)64859-6118395601850669
– reference: Barbera-GuillemENyhusJKWolfordCCFrieceCRSampselJWVascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the processCancer Res20026223704291:CAS:528:DC%2BD38XpsVahtr8%3D12460925
– reference: HicklinDJEllisLMRole of the vascular endothelial growth factor pathway in tumor growth and angiogenesisJ Clin Oncol20052351011271:CAS:528:DC%2BD2MXit1Gnsro%3D10.1200/JCO.2005.06.08115585754
– volume: 12
  start-page: 1232
  issue: 8
  year: 2000
  ident: 3431_CR14
  publication-title: Cytokine
  doi: 10.1006/cyto.2000.0692
– volume: 6
  start-page: 1068
  issue: 4
  year: 2013
  ident: 3431_CR23
  publication-title: Oncol Lett
  doi: 10.3892/ol.2013.1499
– volume: 23
  start-page: 1011
  issue: 5
  year: 2005
  ident: 3431_CR12
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.06.081
– volume: 62
  start-page: 7042
  issue: 23
  year: 2002
  ident: 3431_CR9
  publication-title: Cancer Res
– volume: 54
  start-page: 535
  issue: 2
  year: 2013
  ident: 3431_CR30
  publication-title: J Lipid Res.
  doi: 10.1194/jlr.P030551
– volume: 29
  start-page: 472
  issue: 7
  year: 2011
  ident: 3431_CR37
  publication-title: Cancer Invest
– volume: 96
  start-page: 99
  issue: 2
  year: 2004
  ident: 3431_CR2
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djh014
– volume: 580
  start-page: 2879
  issue: 12
  year: 2006
  ident: 3431_CR26
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2006.03.087
– volume: 184
  start-page: 1273
  issue: 4
  year: 2010
  ident: 3431_CR22
  publication-title: J Urol
  doi: 10.1016/j.juro.2010.06.009
– volume: 2014
  start-page: 932481
  year: 2014
  ident: 3431_CR8
  publication-title: Adv Urol
  doi: 10.1155/2014/932481
– volume: 6
  start-page: e16982
  issue: 2
  year: 2011
  ident: 3431_CR15
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0016982
– volume: 15
  start-page: 653
  issue: 9
  year: 2011
  ident: 3431_CR20
  publication-title: Genet Test Mol Biomarkers
  doi: 10.1089/gtmb.2011.0029
– ident: 3431_CR1
– volume: 35
  start-page: 1307
  issue: 2
  year: 2014
  ident: 3431_CR34
  publication-title: Tumour Biol
  doi: 10.1007/s13277-013-1173-5
– volume: 13
  start-page: 235
  issue: 4
  year: 2013
  ident: 3431_CR17
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-130348
– volume: 48
  start-page: 1171
  issue: 11
  year: 2012
  ident: 3431_CR36
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2012.05.023
– volume: 8
  start-page: 1242
  issue: 4
  year: 2013
  ident: 3431_CR35
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2013.1607
– volume: 103
  start-page: 68
  issue: 1
  year: 2005
  ident: 3431_CR24
  publication-title: Cancer
  doi: 10.1002/cncr.20749
– volume: 31
  start-page: 193
  issue: 9
  year: 2014
  ident: 3431_CR31
  publication-title: Med Oncol
  doi: 10.1007/s12032-014-0193-3
– volume: 4
  issue: 6
  year: 2009
  ident: 3431_CR10
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0005798
– volume: 18
  start-page: 155
  year: 2004
  ident: 3431_CR29
  publication-title: In Vivo
– volume: 168
  start-page: 268
  issue: 3
  year: 2008
  ident: 3431_CR4
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwn122
– volume: 74
  start-page: 98
  issue: 1
  year: 2013
  ident: 3431_CR21
  publication-title: Hum Immunol
  doi: 10.1016/j.humimm.2012.10.014
– volume: 6
  start-page: e19773
  issue: 5
  year: 2011
  ident: 3431_CR13
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0019773
– volume: 24
  start-page: 165
  issue: 2
  year: 2009
  ident: 3431_CR32
  publication-title: Int J Colorectal Dis
  doi: 10.1007/s00384-008-0586-x
– volume: 17
  start-page: 115
  issue: 2
  year: 1994
  ident: 3431_CR5
  publication-title: Diabetes Care
  doi: 10.2337/diacare.17.2.115
– volume: 80
  start-page: 1409
  issue: 15
  year: 2007
  ident: 3431_CR39
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2006.12.033
– volume: 35
  start-page: 3605
  issue: 4
  year: 2014
  ident: 3431_CR18
  publication-title: Tumour Biol
  doi: 10.1007/s13277-013-1475-7
– volume: 19
  start-page: 135
  year: 2010
  ident: 3431_CR27
  publication-title: J Gastrointestin Liver Dis
– volume: 30
  start-page: 509
  issue: 2
  year: 2013
  ident: 3431_CR33
  publication-title: Med Oncol
  doi: 10.1007/s12032-013-0509-8
– volume: 9
  start-page: 1044
  issue: 3
  year: 2014
  ident: 3431_CR19
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2014.1890
– volume: 160
  start-page: 413
  issue: 2
  year: 2002
  ident: 3431_CR38
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)64859-6
– volume: 93
  start-page: 1363
  issue: 8
  year: 2014
  ident: 3431_CR16
  publication-title: J Cancer Res Clin Oncol
– volume: 2
  start-page: 795
  issue: 10
  year: 2002
  ident: 3431_CR11
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc909
– volume: 15
  start-page: 4211
  issue: 10
  year: 2014
  ident: 3431_CR6
  publication-title: Asian Pac J Cancer Prev
  doi: 10.7314/APJCP.2014.15.10.4211
– volume: 208
  start-page: 227
  year: 2004
  ident: 3431_CR28
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2003.11.032
– volume: 19
  start-page: 1
  year: 2014
  ident: 3431_CR7
  publication-title: J Recept Signal Transduct Res
– volume: 97
  start-page: 279
  issue: 2
  year: 2007
  ident: 3431_CR40
  publication-title: Toxicol Sci
  doi: 10.1093/toxsci/kfm060
– volume: 23
  start-page: 2235
  issue: 9
  year: 2012
  ident: 3431_CR3
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mds022
– volume: 20
  start-page: 231
  issue: 3
  year: 2013
  ident: 3431_CR25
  publication-title: Curr Opin Hematol
– reference: 24840096 - J Recept Signal Transduct Res. 2014 Dec;34(6):463-8
– reference: 24127038 - Tumour Biol. 2014 Feb;35(2):1307-11
– reference: 21603628 - PLoS One. 2011;6(5):e19773
– reference: 24137466 - Oncol Lett. 2013 Oct;6(4):1068-1078
– reference: 15142682 - Cancer Lett. 2004 May 28;208(2):227-34
– reference: 20593045 - J Gastrointestin Liver Dis. 2010 Jun;19(2):135-9
– reference: 24240584 - Cancer Biomark. 2013;13(4):235-41
– reference: 22398178 - Ann Oncol. 2012 Sep;23(9):2235-44
– reference: 14734699 - J Natl Cancer Inst. 2004 Jan 21;96(2):99-106
– reference: 18830612 - Int J Colorectal Dis. 2009 Feb;24(2):165-70
– reference: 15113042 - In Vivo. 2004 Mar-Apr;18(2):155-60
– reference: 18544571 - Am J Epidemiol. 2008 Aug 1;168(3):268-77
– reference: 24401996 - Mol Med Rep. 2014 Mar;9(3):1044-8
– reference: 7907975 - Diabetes Care. 1994 Feb;17(2):115-9
– reference: 16631753 - FEBS Lett. 2006 May 22;580(12):2879-87
– reference: 15585754 - J Clin Oncol. 2005 Feb 10;23(5):1011-27
– reference: 19495422 - PLoS One. 2009 Jun 04;4(6):e5798
– reference: 23567339 - Curr Opin Hematol. 2013 May;20(3):231-6
– reference: 12360282 - Nat Rev Cancer. 2002 Oct;2(10):795-803
– reference: 25148899 - Med Oncol. 2014 Sep;31(9):193
– reference: 17286987 - Life Sci. 2007 Mar 20;80(15):1409-14
– reference: 23204297 - J Lipid Res. 2013 Feb;54(2):535-41
– reference: 17369603 - Toxicol Sci. 2007 Jun;97(2):279-87
– reference: 23904001 - Mol Med Rep. 2013 Oct;8(4):1242-50
– reference: 24935373 - Asian Pac J Cancer Prev. 2014;15(10):4211-5
– reference: 21347390 - PLoS One. 2011 Feb 09;6(2):e16982
– reference: 12460925 - Cancer Res. 2002 Dec 1;62(23):7042-9
– reference: 21491998 - Genet Test Mol Biomarkers. 2011 Sep;15(9):653-7
– reference: 24587799 - Adv Urol. 2014;2014:932481
– reference: 15573369 - Cancer. 2005 Jan 1;103(1):68-75
– reference: 11839560 - Am J Pathol. 2002 Feb;160(2):413-8
– reference: 23073296 - Hum Immunol. 2013 Jan;74(1):98-103
– reference: 10930302 - Cytokine. 2000 Aug;12(8):1232-5
– reference: 21740084 - Cancer Invest. 2011 Aug;29(7):472-7
– reference: 20723915 - J Urol. 2010 Oct;184(4):1273-8
– reference: 24310504 - Tumour Biol. 2014 Apr;35(4):3605-10
– reference: 22818823 - Oral Oncol. 2012 Nov;48(11):1171-7
– reference: 23430447 - Med Oncol. 2013 Jun;30(2):509
SSID ssj0015996
Score 2.153465
Snippet We conducted this case–control study to assess the role of vascular endothelial growth factor (VEGF) −2578C/A, +460T/C, +1612G/A, +936C/T, and −634G/C...
We conducted this case-control study to assess the role of vascular endothelial growth factor (VEGF) -2578C/A, +460T/C, +1612G/A, +936C/T, and -634G/C...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 8645
SubjectTerms Adult
Aged
Asian Continental Ancestry Group
Biomedical and Life Sciences
Biomedicine
Cancer Research
Carcinoma, Renal Cell - genetics
Carcinoma, Renal Cell - pathology
Case studies
Female
Genetic Association Studies
Genetic Predisposition to Disease
Genetic Testing
Genotype
Humans
Kidney cancer
Male
Middle Aged
Polymorphism
Prognosis
Research Article
Risk assessment
Risk Factors
Vascular Endothelial Growth Factor A - genetics
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Na9RAFH_YCq0X0Vp1dZURPFmGbpL5SLyIFEsRKh4s7C1kvmphm6yb7cGT_7rvzU52K4t7S8hMMsx7ed_zewDvAyrFqmosz10wXFjX8EpYxYOyZVXm2riGAvqX39TFlfg6ldMUcOtTWeUgE6Ogdp2lGPkpWs5obBdoT3ya_-LUNYqyq6mFxh48jNBlyM96una4MoIeidlOlDUELDZkNePRuYKSlziGF6hDefavXtoyNrcSpVH_nD-Bx8lwZJ9XlH4KD3x7BIdnQ7-2Izi4TGnyZ_Dn-4KuSZIxQvP2rAtsqDllvnV07GqGnMeu0Qtf_mSrrjts3s1-33a48zf9bc-6luEwRsXnNH_h6fsU6GeWGhC1VFn0kTV413ueSt5ZhKs9hqvzLz_OLnjqtMCtEPmS55UL5UQZ9FEVijBlXNmoRqNQrozQRqLVUpSqrLQJLmhvjHLOEbKcKaUMhSyew37btf4lMCO89n6CM70SThVGemUzk9tgssZJP4LJsM-1TTDk1A1jVm8AlIk0NZKmJtLU2Qg-rKfMVxgcuwaPB-LV6Xfs6w3zjODd-jHShzataX13F8foAo0frUbwYkX09dfQ6RNCSpx9MnDBvZf_bymvdi_lNTzKif_iwcYx7C8Xd_4NWjhL8zay8V-fufhz
  priority: 102
  providerName: ProQuest
Title Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case–control study
URI https://link.springer.com/article/10.1007/s13277-015-3431-1
https://www.ncbi.nlm.nih.gov/pubmed/26044558
https://www.proquest.com/docview/1749603508
https://www.proquest.com/docview/1747329376
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB5BKkEvPAqUQKkWiRPIVWzvw-YWopQK1KpCjRROlvdVEKldxc4BTvAb-If8Emb8SIECUi9-7q7t3dl5eGa_AXjmUSimaW6CyHodcGPzIOVGBl6aJE0ipW1OP_QPj-TBjL-Zi3m3jrvqo917l2TDqS8Wu8XkbkTxFcQo9QI0eTZEiA0OYGP8-v3b6dp5QIgjjZMTWQzhifXOzL818rs4uqRjXvKPNmJn_zac9C_cRpt82lvVes98-QPL8YpfdAdudWooG7d0cxeuuWILbk767G9bcOOwc7rfg2_HSzomvsgIG9yx0rM-gpW5wtIirgXSMTtFm77-wNocPuy8XHw-K3EcP1ZnFSsLhsUYhbJT_aWj55PbgBlKZ1RQnNJLluNZ5X58_d6F0LMG_vY-zPanJ5ODoMvcEBjOozqIUuuTkdRo80pkiVLbJJe5Qiafaq60QC0oTmSSKu2tV05raa0lpDqdCOFjET-AQVEW7iEwzZ1yboQ1neRWxlo4aUIdGa_D3Ao3hFE_gJnpYM0pu8YiuwBkpm7OsJsz6uYsHMLzdZXzFtPjf4V3eqrIuuldZWjGoeUXo3I7hKfr2zhC1G154cpVU0bFqEwpOYTtlprWT0MjknMhsPaLnjJ-afxfr_LoSqUfw2ZEpNWsm9yBQb1cuSeoQNV6F66rucJtMgl3u8mD-1fTo-N3eHUWjX8C7-AXyQ
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9wwEB7CBpJeSpO-No9GhfbSIrpry7JdKKV5sWmySygJ5OZYrzawsTfrDSWn_qP-xs7Y1qYlNLfcbCxZQt9oZqR5AbxxKBTTNNc8ME5xoU3OU6Eld1InaRLEyuR0oT8cycGp-HoWnS3Abx8LQ26VnifWjNqUmu7IP6DmjMp2iPrE58kVp6pRZF31JTQasji0Nz_xyFZ9OthFfN8Gwf7eyc6At1UFuBYimPEgNS7pSYXnMYnbVSqT5DKPkQGlSsQqQgkdJjJJY-WMi61S0hhDWdRUEkWurhKBLH9RUERrBxa390bH3-Z2C0p2UttXkbtRKjNvR62D9UIyl2IbHqLU5v1_JeEd9faOabaWePtP4HGrqrIvDW2twIItVmF5x1eIW4WlYWuYfwq_jqf0TLyTUf5wy0rHvJcrs4WhQK8x0jr7juf-2Q_W1Plhk3J8c1ki1hfVZcXKgmEzRu7u1H9qaXwyLTBNJY8K8mX6yHJ8qyxvnexZnSD3GZw-CArPoVOUhX0JTAkbW9vDnlYKI0MVWan7KtBO9XMT2S70_Dpnuk18TvU3xtltymaCJkNoMoIm63fh3bzLpMn6cV_jDQ9e1jKAKrsl1y68nn9GfGjR8sKW13WbOER1K5ZdeNGAPh8Nj5lCRBH2fu-p4K-f_28qa_dPZQuWByfDo-zoYHS4Do8CosU6rHIDOrPptd1E_WqmXrVEzeD8offRH90NNuE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB4hKgGXqrzabXm4Eqcii93EdhJuCFjxFoeuxC2KX22lJVltwqG39jf0H_aXMJPHUgRU4pYoYyfyTObhGX8DsOPRKCZJZnhgvebC2IwnwijulYmTOIi0zWhD__JKnYzE2Y28afucll21e5eSbM40EEpTXu1NrN97OPgWUuoRTRkP0QJyDH_eoDYekKCPgoNZGoGwR-p0JyobQhbr0prPTfHYMD3xNp9kSmsDNHwHb1vPkR00rF6GOZevwOJh17BtBRYu2zz5Kvy-ntI1qTJGcN6OFZ51RafM5ZbOXY1R9Ng3DMOr76xpu8MmxfjnbYFL_6O8LVmRMyRjVH1O46eO3k87_cxQB6KcSov2WYZ3pfv7609b9c5qxNo1GA2Pvx6e8LbZAjdCBBUPEuvjvtIYpirUYkrbOFNZhHo50SLSEh2XMFZxEmlvfeS0VtZaApfTsZQ-lOE6zOdF7j4A08JFzvVxpFPCqlBLp8xAB8brQWal60G_W-nUtEjk1BBjnD5gKBNzUmROSsxJBz34MhsyaWA4_ke80bEvbf_IMsXIC4O1EP3RHnyePUYO0bJluSvuapooRP8nUj1437B99jaM-4SQEkfvdnLwz-QvfcrHV1Fvw8L10TC9OL06_wRLAclmfepxA-ar6Z3bRPen0lu1iN8DIbH93w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictive+value+of+vascular+endothelial+growth+factor+polymorphisms+on+the+risk+of+renal+cell+carcinomas%3A+a+case%E2%80%93control+study&rft.jtitle=Tumor+biology&rft.au=Lu%2C+Guangjian&rft.au=Dong%2C+Yuqian&rft.au=Zhang%2C+Qunmei&rft.au=Jiao%2C+Luyang&rft.date=2015-11-01&rft.issn=1010-4283&rft.eissn=1423-0380&rft.volume=36&rft.issue=11&rft.spage=8645&rft.epage=8652&rft_id=info:doi/10.1007%2Fs13277-015-3431-1&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s13277_015_3431_1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1010-4283&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1010-4283&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1010-4283&client=summon